Moreover, tumor cell vaccines can induce interferon γ (IFN-γ) secretion, which elicits the expression of programmed death ligand 1 (PD-L1) in the tumor and thus induces adaptive immune resistance27. This evidence concerns the gene IFNG and neoplasm.